Advertisement
Screener

PRECIGEN, INC. (PGEN) Increase (Decrease) in Prepaid Expense and Other Assets

2.8 / 5 stars · 68/120 Roast Me

PRECIGEN, INC. Increase (Decrease) in Prepaid Expense and Other Assets

PRECIGEN, INC. (PGEN) reported Increase (Decrease) in Prepaid Expense and Other Assets of $453.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-04

  • PRECIGEN, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$109.00K.
  • PRECIGEN, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $562.00K.
  • PRECIGEN, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$869.00K.
  • PRECIGEN, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $1.87M, a 6.12% decline year-over-year.
  • PRECIGEN, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $93.00K.
  • PRECIGEN, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$981.00K.
  • PRECIGEN, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$748.00K.
  • PRECIGEN, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$2.63M, a 290.17% decline from fiscal 2021.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 3 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2026-06-30-$109.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$453.00K
10-Q · filed 2026-08-04
-$416.00K
derived: sum of 3 quarters · filed 2026-08-04
$1.46M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31$562.00K
10-Q · filed 2026-05-13
-$307.00K
derived: sum of 2 quarters · filed 2026-05-13
$1.56M
derived: sum of 3 quarters · filed 2026-05-13
$701.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31-$869.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$1.00M
derived: sum of 2 quarters · filed 2026-03-25
$139.00K
derived: sum of 3 quarters · filed 2026-08-04
$93.00K
10-K · filed 2026-03-25
2025-09-30$1.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$1.01M
derived: sum of 2 quarters · filed 2026-08-04
$962.00K
10-Q · filed 2025-11-13
-$855.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30-$864.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
-$910.00K
10-Q · filed 2026-08-04
-$2.73M
derived: sum of 3 quarters · filed 2026-08-04
-$733.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31-$46.00K
10-Q · filed 2026-05-13
-$1.86M
derived: sum of 2 quarters · filed 2026-05-13
$131.00K
derived: sum of 3 quarters · filed 2026-05-13
-$328.00K
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$1.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$177.00K
derived: sum of 2 quarters · filed 2026-03-25
-$282.00K
derived: sum of 3 quarters · filed 2026-03-25
-$981.00K
10-K · filed 2026-03-25
2024-09-30$1.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$1.53M
derived: sum of 2 quarters · filed 2025-11-13
$836.00K
10-Q · filed 2025-11-13
$26.00K
derived: sum of 4 quarters · filed 2026-03-25
2024-06-30-$459.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
-$1.16M
10-Q · filed 2025-08-12
-$1.97M
derived: sum of 3 quarters · filed 2026-03-25
$368.00K
derived: sum of 4 quarters · filed 2026-03-25
2024-03-31-$699.00K
10-Q · filed 2025-05-14
-$1.51M
derived: sum of 2 quarters · filed 2026-03-25
$827.00K
derived: sum of 3 quarters · filed 2026-03-25
-$704.00K
derived: sum of 4 quarters · filed 2026-03-25
2023-12-31-$810.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$1.53M
derived: sum of 2 quarters · filed 2026-03-25
-$5.00K
derived: sum of 3 quarters · filed 2026-03-25
-$748.00K
10-K · filed 2026-03-25
2023-09-30$2.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$805.00K
derived: sum of 2 quarters · filed 2024-11-14
$62.00K
10-Q · filed 2024-11-14
-$1.47M
derived: sum of 4 quarters · filed 2025-03-19
2023-06-30-$1.53M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
-$2.27M
10-Q · filed 2024-08-14
-$3.80M
derived: sum of 3 quarters · filed 2025-03-19
-$620.00K
derived: sum of 4 quarters · filed 2025-03-19
2023-03-31-$743.00K
10-Q · filed 2024-05-14
-$2.27M
derived: sum of 2 quarters · filed 2025-03-19
$911.00K
derived: sum of 3 quarters · filed 2025-03-19
-$1.27M
derived: sum of 4 quarters · filed 2025-03-19
2022-12-31-$1.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19
$1.65M
derived: sum of 2 quarters · filed 2025-03-19
-$528.00K
derived: sum of 3 quarters · filed 2025-03-19
-$2.63M
10-K · filed 2025-03-19
-$289.00K
10-K · filed 2023-03-06
2022-09-30$3.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$999.00K
derived: sum of 2 quarters · filed 2023-11-09
-$1.10M
10-Q · filed 2023-11-09
$1.30M
10-Q · filed 2022-11-09
-$108.00K
derived: sum of 4 quarters · filed 2024-03-19
2022-06-30-$2.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$4.28M
10-Q · filed 2023-08-09
-$3.52M
10-Q · filed 2022-08-08
-$3.29M
derived: sum of 3 quarters · filed 2024-03-19
$893.00K
derived: sum of 4 quarters · filed 2024-03-19
2022-03-31-$2.10M
10-Q · filed 2023-05-10
-$1.57M
10-Q · filed 2022-05-09
-$1.11M
derived: sum of 2 quarters · filed 2024-03-19
$3.08M
derived: sum of 3 quarters · filed 2024-03-19
$125.00K
derived: sum of 4 quarters · filed 2024-03-19
2021-12-31$995.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19
$5.18M
derived: sum of 2 quarters · filed 2024-03-19
$2.23M
derived: sum of 3 quarters · filed 2024-03-19
$1.38M
10-K · filed 2024-03-19
-$520.00K
10-K · filed 2022-03-01
2021-09-30$4.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$1.23M
derived: sum of 2 quarters · filed 2022-11-09
$388.00K
10-Q · filed 2022-11-09
-$577.00K
derived: sum of 4 quarters · filed 2023-03-06
2021-06-30-$2.95M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
-$3.79M
10-Q · filed 2022-08-08
-$4.76M
derived: sum of 3 quarters · filed 2023-03-06
$279.00K
derived: sum of 4 quarters · filed 2023-03-06
2021-03-31-$844.00K
10-Q · filed 2022-05-09
-$1.81M
derived: sum of 2 quarters · filed 2023-03-06
$3.23M
derived: sum of 3 quarters · filed 2023-03-06
$895.00K
derived: sum of 4 quarters · filed 2023-03-06
2020-12-31-$965.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06
$4.07M
derived: sum of 2 quarters · filed 2023-03-06
$1.74M
derived: sum of 3 quarters · filed 2023-03-06
$812.00K
10-K · filed 2023-03-06
2020-09-30$5.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
$2.70M
derived: sum of 2 quarters · filed 2021-11-08
$1.78M
10-Q · filed 2021-11-08
-$281.00K
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30-$2.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
-$3.26M
10-Q · filed 2021-08-09
-$5.32M
derived: sum of 3 quarters · filed 2022-03-01
-$954.00K
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31-$927.00K
10-Q · filed 2021-05-10
-$2.98M
derived: sum of 2 quarters · filed 2022-03-01
$1.38M
derived: sum of 3 quarters · filed 2022-03-01
$1.01M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31-$2.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$2.31M
derived: sum of 2 quarters · filed 2022-03-01
$1.94M
derived: sum of 3 quarters · filed 2022-03-01
$2.26M
10-K · filed 2022-03-01
2019-09-30$4.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$4.00M
derived: sum of 2 quarters · filed 2020-11-09
$4.32M
10-Q · filed 2020-11-09
$2.80M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30-$367.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
-$45.00K
10-Q · filed 2020-08-10
-$1.56M
derived: sum of 3 quarters · filed 2021-03-01
$233.00K
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31$322.00K
10-Q · filed 2020-05-11
-$1.20M
derived: sum of 2 quarters · filed 2021-03-01
$600.00K
derived: sum of 3 quarters · filed 2021-03-01
$378.00K
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31-$1.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$278.00K
derived: sum of 2 quarters · filed 2021-03-01
$56.00K
derived: sum of 3 quarters · filed 2021-03-01
-$1.01M
10-K · filed 2021-03-01
2018-09-30$1.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$1.57M
derived: sum of 2 quarters · filed 2019-11-12
$511.00K
10-Q · filed 2019-11-12
-$497.00K
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30-$222.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
-$1.28M
10-Q · filed 2019-08-09
-$2.29M
derived: sum of 3 quarters · filed 2020-03-02
-$1.30M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31-$1.06M
10-Q · filed 2019-05-09
-$2.07M
derived: sum of 2 quarters · filed 2020-03-02
-$1.08M
derived: sum of 3 quarters · filed 2020-03-02
-$1.34M
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31-$1.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
-$21.00K
derived: sum of 2 quarters · filed 2020-03-02
-$282.00K
derived: sum of 3 quarters · filed 2020-03-02
-$492.00K
10-K · filed 2020-03-02
2017-09-30$987.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$726.00K
derived: sum of 2 quarters · filed 2018-11-08
$516.00K
10-Q · filed 2018-11-08
$463.00K
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30-$261.00K
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-13
-$471.00K
10-Q · filed 2018-08-13
-$524.00K
derived: sum of 3 quarters · filed 2019-03-01
$1.76M
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31-$210.00K
10-Q/A · filed 2018-08-13
-$263.00K
derived: sum of 2 quarters · filed 2019-03-01
$2.02M
derived: sum of 3 quarters · filed 2019-03-01
$865.00K
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31-$53.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
$2.23M
derived: sum of 2 quarters · filed 2019-03-01
$1.07M
derived: sum of 3 quarters · filed 2019-03-01
$932.00K
10-K · filed 2019-03-01
2016-09-30$2.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$1.13M
derived: sum of 2 quarters · filed 2017-11-09
$985.00K
10-Q · filed 2017-11-09
-$291.00K
derived: sum of 4 quarters · filed 2018-03-01
2016-06-30-$1.16M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
-$1.30M
10-Q · filed 2017-08-09
-$2.58M
derived: sum of 3 quarters · filed 2018-03-01
-$239.00K
derived: sum of 4 quarters · filed 2018-03-01
2016-03-31-$143.00K
10-Q · filed 2017-05-10
-$1.42M
derived: sum of 2 quarters · filed 2018-03-01
$917.00K
derived: sum of 3 quarters · filed 2018-03-01
$2.29M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31-$1.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
$1.06M
derived: sum of 2 quarters · filed 2018-03-01
$2.44M
derived: sum of 3 quarters · filed 2018-03-01
$2.73M
10-K · filed 2018-03-01
2015-09-30$2.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$3.71M
derived: sum of 2 quarters · filed 2016-11-09
$4.00M
10-Q · filed 2016-11-09
$3.79M
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30$1.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$1.67M
10-Q · filed 2016-08-09
$1.46M
derived: sum of 3 quarters · filed 2017-03-01
$1.90M
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31$292.00K
10-Q · filed 2016-05-10
$78.00K
derived: sum of 2 quarters · filed 2017-03-01
$522.00K
derived: sum of 3 quarters · filed 2017-03-01
$759.00K
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31-$214.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
$230.00K
derived: sum of 2 quarters · filed 2017-03-01
$467.00K
derived: sum of 3 quarters · filed 2017-03-01
$465.00K
10-K · filed 2017-03-01
2014-09-30$444.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
$681.00K
derived: sum of 2 quarters · filed 2015-11-09
$679.00K
10-Q · filed 2015-11-09
$398.00K
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$237.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
$235.00K
10-Q · filed 2015-08-10
-$46.00K
derived: sum of 3 quarters · filed 2016-02-29
$1.33M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31-$2.00K
10-Q · filed 2015-05-11
-$283.00K
derived: sum of 2 quarters · filed 2016-02-29
$1.09M
derived: sum of 3 quarters · filed 2016-02-29
$454.00K
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31-$281.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$1.09M
derived: sum of 2 quarters · filed 2016-02-29
$456.00K
derived: sum of 3 quarters · filed 2016-02-29
$347.00K
10-K · filed 2016-02-29
2013-09-30$1.38M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13
$737.00K
derived: sum of 2 quarters · filed 2014-11-13
$628.00K
10-Q · filed 2014-11-13
$506.00K
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30-$638.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14
-$747.00K
10-Q · filed 2014-08-14
-$869.00K
derived: sum of 3 quarters · filed 2015-03-02
-$939.00K
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31-$109.00K
10-Q · filed 2014-05-09
-$231.00K
derived: sum of 2 quarters · filed 2015-03-02
-$301.00K
derived: sum of 3 quarters · filed 2015-03-02
2012-12-31-$122.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
-$192.00K
derived: sum of 2 quarters · filed 2015-03-02
$413.00K
10-K · filed 2015-03-02
2012-09-30-$70.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-07
$535.00K
10-Q · filed 2013-11-07
2012-06-30$605.00K
10-Q/A · filed 2013-10-21
2011-12-31$772.00K
10-K · filed 2014-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
NewAmsterdam Pharma Co N.V. (NAMS)$2.719B-15.37
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Immunome Inc. (IMNM)United States$2.538B-9.45
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67